Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Trends & Forecasts

Manufacture Business Practice

Why Aren’t We Connecting?

| Kal Patel

Digital technology is all around us, but pharma isn’t quite getting it right… yet.

Business & Regulation Standards & Regulation

The True Cost of Falsified Medicine

| Roisin McGuigan

A recent review and meta-analysis highlights the huge impact of fake and substandard drugs.

Discovery & Development Business Practice

The Power to Change Lives

| Stephanie Sutton

Sitting Down With…Danny Bar-Zohar, Global Head of Neuroscience Development at Novartis, Switzerland

Discovery & Development Business Practice

Antibody About Turn

| Sam Cobb

A promising candidate is on the verge of entering clinical development… What happens when you see an opportunity to make it even better?

Business & Regulation Small Molecules

Kaizen Chiefs

| Chris Owen

The automotive sector – Toyota, in particular – is a rich source of inspiration for improving productivity.

Business & Regulation Technology and Equipment

Towards Industry 4.0

| James Strachan

The fourth industrial revolution – Industry 4.0 – represents a shift in manufacturing mentality. Is biopharma ready?

Manufacture Business Practice

Business-in-Brief

| Stephanie Sutton

After many years of clinical trial failures in Alzheimer’s disease, pharma sees some positive results – although caution is recommended.

Business & Regulation Business Practice

Let’s Talk About Mental Health

| Roisin McGuigan

A recent survey examined the relationships – or lack thereof – between pharma companies and mental health patient groups

Business & Regulation Business Practice

Knowing Your Values

| Stephanie Sutton

Does a medicine’s price consistently track with its benefits and value? Not in the US, according to a study.

Business & Regulation Business Practice

For Patients, Not Profits

A new not-for-profit company will manufacture important generics in the US

Newsletter

Send me the latest from The Medicine Maker.

Sign up now

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register